India starts national registry for stroke patients

Updated on 18 January 2013

The National Registry for Stroke programme will be spearheaded by Bangalore-based National Centre for Disease Informatics and Research (NCDIR), a constituent unit of Delhi-based Indian Council for Medical Research

india-s-national-centre-for-disease-informatics-and-research-ncdir-will-be-the-hub-for-setting-up-of-the-national-registry-for-stroke

India’s National Centre for Disease Informatics and Research (NCDIR) will be the hub for setting up of the National Registry for Stroke

Bangalore: After the successful compilation of India's National Cancer Registry, the first of its kind for any disease in the country over the last two decades, the government has embarked on an ambitious project to prepare a National Registry for Stroke in 2013.

The stroke registry programme will be spearheaded by Bangalore-based National Centre for Disease Informatics and Research (NCDIR) which is a constituent unit of Delhi-based Indian Council for Medical Research. Work on the National Cancer Registry started in 1982 and eventually the programme led to the formation of NCDIR. The institution has the mandate to prepare national registries for other diseases such as diabetes and coronary vascular disease. Stroke is the second diseased tackled by NCDIR.

NCDIR's director-in-charge, Dr A Nandakumar, recently kicked off the programme recently inviting all neurologists, radiologists, community and public health professionals and physicians treating stroke patients across the country to register their patients with the institution. Just like the cancer registry, initially the registry will seek to access data from at least top 20 locations in the country.

The registry will use information technology tools effectively to capture data about stroke patients from across the country. "The proposal envisages using electronic information technology in collecting information on stroke cases as and when they are reported," wrote Dr Nandakumar in his invitation letter to medical professionals.

Initially, the registry will be a national in coverage. Later, if the response is good, there will be compilation even population based registers for various cities. This has been done in the case of cancer registry.

Previous 1

Leave a Reply

Notify me of follow-up comments via e-mail address

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X